Literature DB >> 27095048

The Persistence of Tinnitus after Acoustic Neuroma Surgery.

Jason R Bell1, Sara J Anderson-Kim2, Christopher Low3, John P Leonetti2.   

Abstract

OBJECTIVE: Examine possible prognostic factors for the persistence of tinnitus after acoustic neuroma resection. STUDY
DESIGN: Case series with chart review.
SETTING: Tertiary academic medical center. SUBJECTS AND METHODS: The records of 166 patients who underwent acoustic neuroma resection from 2009 to 2014 were reviewed. Patients were asked to complete a survey, including the Tinnitus Handicap Inventory, 1 to 6 years postoperatively.
RESULTS: Of the 53 patients who completed the survey, 17% reported that their tinnitus resolved; 9% reported improvement; 23% reported no change; 43% reported that their tinnitus worsened; and 8% were unsure. Respondents ≥50 years old and those with nonserviceable hearing preoperatively were more likely to report that their tinnitus resolved or improved (P < .01 and P = .02, respectively). Respondents <50 years old and those with serviceable hearing preoperatively were more likely to report that their tinnitus was the same or worse (P < .001 and P = .036, respectively). Respondents with age <50 years, serviceable hearing preoperatively, and residual tumor had a higher average Tinnitus Handicap Inventory score (P = .016, P = .048, and P = .047, respectively). Sex, tumor size, surgical approach, hearing preservation, and cochlear nerve status did not correlate with the prognosis of tinnitus postoperatively. Respondents whose tinnitus resolved postoperatively were more likely to report being "very satisfied" with their care (P = .012).
CONCLUSION: In this study, 83% of respondents had persistent tinnitus after acoustic neuroma resection. The prognosis of tinnitus was worse for younger respondents, those with serviceable hearing preoperatively, and those with residual tumor postoperatively. Respondents' satisfaction was higher if their tinnitus resolved. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  Tinnitus Handicap Inventory; acoustic neuroma; resection; surgery; tinnitus; vestibular schwannoma

Mesh:

Year:  2016        PMID: 27095048     DOI: 10.1177/0194599816642427

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Cochlear Implantation in Sporadic Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Matthew Robert Bartindale; Kent Sean Tadokoro; Matthew Lowell Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-08

2.  Predictors of Preoperative Tinnitus in Unilateral Sporadic Vestibular Schwannoma.

Authors:  Georgios Naros; Joey Sandritter; Marina Liebsch; Alex Ofori; Ahmed R Rizk; Giulia Del Moro; Florian Ebner; Marcos Tatagiba
Journal:  Front Neurol       Date:  2017-08-03       Impact factor: 4.003

3.  Changes in tinnitus after vestibular schwannoma surgery.

Authors:  Jing-Jing Wang; Yan-Mei Feng; Hui Wang; Ya-Qin Wu; Hai-Bo Shi; Zheng-Nong Chen; Shan-Kai Yin
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

4.  Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.

Authors:  Daniele Starnoni; Lorenzo Giammattei; Giulia Cossu; Michael J Link; Pierre-Hugues Roche; Ari G Chacko; Kenji Ohata; Majid Samii; Ashish Suri; Michael Bruneau; Jan F Cornelius; Luigi Cavallo; Torstein R Meling; Sebastien Froelich; Marcos Tatagiba; Albert Sufianov; Dimitrios Paraskevopoulos; Idoya Zazpe; Moncef Berhouma; Emmanuel Jouanneau; Jeroen B Verheul; Constantin Tuleasca; Mercy George; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel
Journal:  Acta Neurochir (Wien)       Date:  2020-07-29       Impact factor: 2.216

5.  Cochlear Implantation for Patients with a Vestibular Schwannoma: Effect on Tinnitus Handicap.

Authors:  Niels West; Marie Bunne; Hjalte Sass; Per Cayé-Thomasen
Journal:  J Int Adv Otol       Date:  2022-09       Impact factor: 1.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.